GNPTA_HUMAN - dbPTM
GNPTA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GNPTA_HUMAN
UniProt AC Q3T906
Protein Name N-acetylglucosamine-1-phosphotransferase subunits alpha/beta
Gene Name GNPTAB
Organism Homo sapiens (Human).
Sequence Length 1256
Subcellular Localization N-acetylglucosamine-1-phosphotransferase subunit alpha: Golgi apparatus membrane
Single-pass type I membrane protein .
N-acetylglucosamine-1-phosphotransferase subunit beta: Golgi apparatus membrane
Single-pass type II membrane protein .
Protein Description Catalyzes the formation of mannose 6-phosphate (M6P) markers on high mannose type oligosaccharides in the Golgi apparatus. M6P residues are required to bind to the M6P receptors (MPR), which mediate the vesicular transport of lysosomal enzymes to the endosomal/prelysosomal compartment..
Protein Sequence MLFKLLQRQTYTCLSHRYGLYVCFLGVVVTIVSAFQFGEVVLEWSRDQYHVLFDSYRDNIAGKSFQNRLCLPMPIDVVYTWVNGTDLELLKELQQVREQMEEEQKAMREILGKNTTEPTKKSEKQLECLLTHCIKVPMLVLDPALPANITLKDLPSLYPSFHSASDIFNVAKPKNPSTNVSVVVFDSTKDVEDAHSGLLKGNSRQTVWRGYLTTDKEVPGLVLMQDLAFLSGFPPTFKETNQLKTKLPENLSSKVKLLQLYSEASVALLKLNNPKDFQELNKQTKKNMTIDGKELTISPAYLLWDLSAISQSKQDEDISASRFEDNEELRYSLRSIERHAPWVRNIFIVTNGQIPSWLNLDNPRVTIVTHQDVFRNLSHLPTFSSPAIESHIHRIEGLSQKFIYLNDDVMFGKDVWPDDFYSHSKGQKVYLTWPVPNCAEGCPGSWIKDGYCDKACNNSACDWDGGDCSGNSGGSRYIAGGGGTGSIGVGQPWQFGGGINSVSYCNQGCANSWLADKFCDQACNVLSCGFDAGDCGQDHFHELYKVILLPNQTHYIIPKGECLPYFSFAEVAKRGVEGAYSDNPIIRHASIANKWKTIHLIMHSGMNATTIHFNLTFQNTNDEEFKMQITVEVDTREGPKLNSTAQKGYENLVSPITLLPEAEILFEDIPKEKRFPKFKRHDVNSTRRAQEEVKIPLVNISLLPKDAQLSLNTLDLQLEHGDITLKGYNLSKSALLRSFLMNSQHAKIKNQAIITDETNDSLVAPQEKQVHKSILPNSLGVSERLQRLTFPAVSVKVNGHDQGQNPPLDLETTARFRVETHTQKTIGGNVTKEKPPSLIVPLESQMTKEKKITGKEKENSRMEENAENHIGVTEVLLGRKLQHYTDSYLGFLPWEKKKYFQDLLDEEESLKTQLAYFTDSKNTGRQLKDTFADSLRYVNKILNSKFGFTSRKVPAHMPHMIDRIVMQELQDMFPEEFDKTSFHKVRHSEDMQFAFSYFYYLMSAVQPLNISQVFDEVDTDQSGVLSDREIRTLATRIHELPLSLQDLTGLEHMLINCSKMLPADITQLNNIPPTQESYYDPNLPPVTKSLVTNCKPVTDKIHKAYKDKNKYRFEIMGEEEIAFKMIRTNVSHVVGQLDDIRKNPRKFVCLNDNIDHNHKDAQTVKAVLRDFYESMFPIPSQFELPREYRNRFLHMHELQEWRAYRDKLKFWTHCVLATLIMFTIFSFFAEQLIALKRKIFPRRRIHKEASPNRIRV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Ubiquitination----MLFKLLQRQTY
----CHHHHHHHHHH
62.0121890473
4 (in isoform 2)Ubiquitination-62.0121890473
4 (in isoform 1)Ubiquitination-62.0121890473
49PhosphorylationLEWSRDQYHVLFDSY
EEECHHCEEEEEHHH
9.74-
83N-linked_GlycosylationDVVYTWVNGTDLELL
CEEEEEECCCCHHHH
38.93UniProtKB CARBOHYD
114N-linked_GlycosylationMREILGKNTTEPTKK
HHHHHCCCCCCCCCC
50.89UniProtKB CARBOHYD
115PhosphorylationREILGKNTTEPTKKS
HHHHCCCCCCCCCCC
35.70-
131PhosphorylationKQLECLLTHCIKVPM
HHHHHHHHHHCCCCE
11.1822210691
148N-linked_GlycosylationLDPALPANITLKDLP
CCCCCCCCCCHHCCH
26.32UniProtKB CARBOHYD
150PhosphorylationPALPANITLKDLPSL
CCCCCCCCHHCCHHH
27.8022210691
179N-linked_GlycosylationKPKNPSTNVSVVVFD
CCCCCCCCEEEEEEE
28.53UniProtKB CARBOHYD
245PhosphorylationKETNQLKTKLPENLS
HHHHHHHHCCCCCHH
46.5425003641
250N-linked_GlycosylationLKTKLPENLSSKVKL
HHHCCCCCHHHHHHH
43.19UniProtKB CARBOHYD
289PhosphorylationKQTKKNMTIDGKELT
HHCCCCCEECCEECE
25.88-
312PhosphorylationDLSAISQSKQDEDIS
HHHHHHCCCCCCCCC
26.03-
319PhosphorylationSKQDEDISASRFEDN
CCCCCCCCCCCCCCC
32.30-
321PhosphorylationQDEDISASRFEDNEE
CCCCCCCCCCCCCHH
30.61-
332PhosphorylationDNEELRYSLRSIERH
CCHHHHHHHHHHHHH
15.7524719451
459PhosphorylationCDKACNNSACDWDGG
CCCCCCCCCCCCCCC
19.1124114839
472PhosphorylationGGDCSGNSGGSRYIA
CCCCCCCCCCCCEEC
48.3224114839
475PhosphorylationCSGNSGGSRYIAGGG
CCCCCCCCCEECCCC
25.9924114839
573UbiquitinationFSFAEVAKRGVEGAY
CCHHHHHHHCCCCCC
55.66-
614N-linked_GlycosylationNATTIHFNLTFQNTN
CCEEEEEEEEEECCC
24.82UniProtKB CARBOHYD
654O-linked_GlycosylationKGYENLVSPITLLPE
HCHHCCCCCCHHCCH
17.47OGP
657O-linked_GlycosylationENLVSPITLLPEAEI
HCCCCCCHHCCHHHH
26.15OGP
699N-linked_GlycosylationEVKIPLVNISLLPKD
HCCCCEEECCCCCCC
26.3019159218
713O-linked_GlycosylationDAQLSLNTLDLQLEH
CCCCCCCCEEEEECC
27.26OGP
728PhosphorylationGDITLKGYNLSKSAL
CCEEEEECCCCHHHH
16.02-
729N-linked_GlycosylationDITLKGYNLSKSALL
CEEEEECCCCHHHHH
46.65UniProtKB CARBOHYD
731PhosphorylationTLKGYNLSKSALLRS
EEEECCCCHHHHHHH
22.41-
733PhosphorylationKGYNLSKSALLRSFL
EECCCCHHHHHHHHH
22.29-
755PhosphorylationIKNQAIITDETNDSL
CCCCEEEECCCCCCC
22.9720230923
755O-linked_GlycosylationIKNQAIITDETNDSL
CCCCEEEECCCCCCC
22.97OGP
758PhosphorylationQAIITDETNDSLVAP
CEEEECCCCCCCCCC
47.3224850871
761PhosphorylationITDETNDSLVAPQEK
EECCCCCCCCCCCCH
27.1520230923
773O-linked_GlycosylationQEKQVHKSILPNSLG
CCHHHCHHHCCCCCC
17.93OGP
778O-linked_GlycosylationHKSILPNSLGVSERL
CHHHCCCCCCHHHHH
25.26OGP
782O-linked_GlycosylationLPNSLGVSERLQRLT
CCCCCCHHHHHHHCC
18.3955835617
789O-linked_GlycosylationSERLQRLTFPAVSVK
HHHHHHCCCCEEEEE
29.7555828949
794O-linked_GlycosylationRLTFPAVSVKVNGHD
HCCCCEEEEEECCCC
20.5155828955
812O-linked_GlycosylationNPPLDLETTARFRVE
CCCCCHHHCEEEEEE
32.8155825241
813O-linked_GlycosylationPPLDLETTARFRVET
CCCCHHHCEEEEEEE
13.3755825247
820O-linked_GlycosylationTARFRVETHTQKTIG
CEEEEEEECCCCCCC
27.63OGP
822O-linked_GlycosylationRFRVETHTQKTIGGN
EEEEEECCCCCCCCC
38.90OGP
825PhosphorylationVETHTQKTIGGNVTK
EEECCCCCCCCCCCC
18.29-
829N-linked_GlycosylationTQKTIGGNVTKEKPP
CCCCCCCCCCCCCCC
32.83UniProtKB CARBOHYD
831PhosphorylationKTIGGNVTKEKPPSL
CCCCCCCCCCCCCCE
37.17-
837O-linked_GlycosylationVTKEKPPSLIVPLES
CCCCCCCCEEEECCH
38.9855833983
837PhosphorylationVTKEKPPSLIVPLES
CCCCCCCCEEEECCH
38.98-
844PhosphorylationSLIVPLESQMTKEKK
CEEEECCHHCCCCCC
32.70-
844O-linked_GlycosylationSLIVPLESQMTKEKK
CEEEECCHHCCCCCC
32.7046220749
847O-linked_GlycosylationVPLESQMTKEKKITG
EECCHHCCCCCCCCC
28.5411036755
847PhosphorylationVPLESQMTKEKKITG
EECCHHCCCCCCCCC
28.54-
873O-linked_GlycosylationAENHIGVTEVLLGRK
HHHHCCHHHHHHCCH
18.3755830809
899PhosphorylationLPWEKKKYFQDLLDE
CCHHHHHHHHHHCCH
18.4924719451
909PhosphorylationDLLDEEESLKTQLAY
HHCCHHHHHHHHHHH
38.1424719451
1009N-linked_GlycosylationMSAVQPLNISQVFDE
HHHHCCCCHHHHCCC
38.25UniProtKB CARBOHYD
1011PhosphorylationAVQPLNISQVFDEVD
HHCCCCHHHHCCCCC
21.1526330541
1019PhosphorylationQVFDEVDTDQSGVLS
HHCCCCCCCCCCCCC
40.9122210691
1022PhosphorylationDEVDTDQSGVLSDRE
CCCCCCCCCCCCHHH
33.4122210691
1026PhosphorylationTDQSGVLSDREIRTL
CCCCCCCCHHHHHHH
32.0126330541
1074O-linked_GlycosylationQLNNIPPTQESYYDP
HHCCCCCCCHHHCCC
39.35OGP
1077PhosphorylationNIPPTQESYYDPNLP
CCCCCCHHHCCCCCC
21.1228387310
1079PhosphorylationPPTQESYYDPNLPPV
CCCCHHHCCCCCCCC
33.9228387310
1098O-linked_GlycosylationVTNCKPVTDKIHKAY
HHCCEECCHHHHHHH
39.8555833859
1128PhosphorylationIAFKMIRTNVSHVVG
HHHHHHHHHHHHHHC
29.10-
1129N-linked_GlycosylationAFKMIRTNVSHVVGQ
HHHHHHHHHHHHHCC
24.36UniProtKB CARBOHYD
1131PhosphorylationKMIRTNVSHVVGQLD
HHHHHHHHHHHCCHH
16.78-
1250PhosphorylationRRIHKEASPNRIRV-
CHHCCCCCCCCCCC-
24.6525159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of GNPTA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GNPTA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GNPTA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
MK01_HUMANMAPK1physical
21988832

Drug and Disease Associations
Kegg Disease
H00143 Mucolipidosis II and III, including: Mucolipidosis II / I-cell disease; Mucolipidosis III A / Pseudo
OMIM Disease
252500Mucolipidosis type II (MLII)
252600Mucolipidosis type III complementation group A (MLIIIA)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GNPTA_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-699, AND MASSSPECTROMETRY.

TOP